XML 28 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Value Measurements (Tables)
12 Months Ended
May. 31, 2015
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company's financial assets and liabilities measured at fair value on a recurring basis as of May 31, 2015 and 2014 and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value. Refer to Note 1 — Summary of Significant Accounting Policies for additional detail regarding the Company’s fair value measurement methodology.
 
 
As of May 31, 2015
(In millions)
 
Assets at Fair Value
 
Cash and Cash Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
615

 
$
615

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
869

 
225

 
644

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
684

 
684

 

 

U.S. Agency securities
 
976

 
110

 
866

 

Commercial paper and bonds
 
914

 
352

 
562

 

Money market funds
 
1,866

 
1,866

 

 

Total level 2
 
4,440

 
3,012

 
1,428

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
8

 

 

 
8

TOTAL
 
$
5,932

 
$
3,852

 
$
2,072

 
$
8

 
 
 
As of May 31, 2014
(In millions)
 
Assets at Fair Value
 
Cash and Cash Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
780

 
$
780

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
1,137

 
151

 
986

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
227

 
227

 

 

U.S. Agency securities
 
1,027

 
25

 
1,002

 

Commercial paper and bonds
 
959

 
25

 
934

 

Money market funds
 
1,012

 
1,012

 

 

Total level 2
 
3,225

 
1,289

 
1,936

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
7

 

 

 
7

TOTAL
 
$
5,149

 
$
2,220

 
$
2,922

 
$
7


Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following tables present information about the Company’s derivative assets and liabilities measured at fair value on a recurring basis as of May 31, 2015 and May 31, 2014, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of May 31, 2015
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
1,554

 
$
1,034

 
$
520

 
$
164

 
$
160

 
$
4

Embedded derivatives
 
7

 
2

 
5

 
11

 
2

 
9

Interest rate swaps(2)
 
78

 
78

 

 

 

 

TOTAL
 
$
1,639

 
$
1,114

 
$
525

 
$
175

 
$
162

 
$
13

(1)
If the foreign exchange derivative instruments had been netted in the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $161 million as of May 31, 2015. As of that date, the Company had received $900 million of cash collateral and $74 million of securities from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of May 31, 2015.
(2)
As of May 31, 2015, the Company had received $68 million of cash collateral related to its interest rate swaps.
 
 
As of May 31, 2014
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
127

 
$
101

 
$
26

 
$
85

 
$
84

 
$
1

Interest rate swaps
 
6

 

 
6

 

 

 

TOTAL
 
$
133

 
$
101

 
$
32

 
$
85

 
$
84

 
$
1

(1)
If the foreign exchange derivative financial instruments had been netted in the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $63 million as of May 31, 2014. No amounts of collateral were received or posted on the Company’s derivative assets and liabilities as of May 31, 2014.
The following table presents the fair values of derivative instruments included within the Consolidated Balance Sheets as of May 31, 2015 and 2014: 
 
 
Asset Derivatives
 
Liability Derivatives
(In millions)
 
Balance Sheet
Location
 
2015
 
2014
 
Balance Sheet 
Location
 
2015
 
2014
Derivatives formally designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
$
825

 
$
76

 
Accrued liabilities
 
$
140

 
$
57

Interest rate swaps
 
Prepaid expenses and other current assets
 
78

 

 
Accrued liabilities
 

 

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
520

 
26

 
Deferred income taxes and other liabilities
 
4

 
1

Interest rate swaps
 
Deferred income taxes and other assets
 

 
6

 
Deferred income taxes and other liabilities
 

 

Total derivatives formally designated as hedging instruments
 
 
 
1,423

 
108

 
 
 
144

 
58

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
209

 
25

 
Accrued liabilities
 
20

 
27

Embedded derivatives
 
Prepaid expenses and other current assets
 
2

 

 
Accrued liabilities
 
2

 

Embedded derivatives
 
Deferred income taxes and other assets
 
5

 

 
Deferred income taxes and other liabilities
 
9

 

Total derivatives not designated as hedging instruments
 
 
 
216

 
25

 
 
 
31

 
27

TOTAL DERIVATIVES
 
 
 
$
1,639

 
$
133

 
 
 
$
175

 
$
85